Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival

Hernando Lopez-Bertoni, Kristen L. Kozielski, Yuan Rui, Bachchu Lal, Hannah Vaughan, David R. Wilson, Nicole Mihelson, Charles G Eberhart, John J Laterra, Jordan Green

Research output: Contribution to journalArticle

Abstract

Despite our growing molecular-level understanding of glioblastoma (GBM), treatment modalities remain limited. Recent developments in the mechanisms of cell fate regulation and nanomedicine provide new avenues by which to treat and manage brain tumors via the delivery of molecular therapeutics. Here, we have developed bioreducible poly(β-amino ester) nanoparticles that demonstrate high intracellular delivery efficacy, low cytotoxicity, escape from endosomes, and promotion of cytosol-targeted environmentally triggered cargo release for miRNA delivery to tumor-propagating human cancer stem cells. In this report, we combined this nanobiotechnology with newly discovered cancer stem cell inhibiting miRNAs to develop self-assembled miRNA-containing polymeric nanoparticles (nano-miRs) to treat gliomas. We show that these nano-miRs effectively intracellularly deliver single and combination miRNA mimics that inhibit the stem cell phenotype of human GBM cells in vitro. Following direct intratumoral infusion, these nano-miRs were found to distribute through the tumors, inhibit the growth of established orthotopic human GBM xenografts, and cooperatively enhance the response to standard-of-care γ radiation. Co-delivery of two miRNAs, miR-148a and miR-296-5p, within the bioreducible nano-miR particles enabled long-term survival from GBM in mice.

Original languageEnglish (US)
Pages (from-to)4086-4094
Number of pages9
JournalNano Letters
Volume18
Issue number7
DOIs
StatePublished - Jul 11 2018

Fingerprint

stem cells
Stem cells
MicroRNAs
Tumors
delivery
cancer
Nanoparticles
nanoparticles
tumors
Nanobiotechnology
Medical nanotechnology
Cytotoxicity
phenotype
cargo
Brain
Esters
promotion
cells
escape
brain

Keywords

  • bioreducible
  • brain cancer
  • cancer stem cell
  • miRNA
  • nanomedicine
  • polymer

ASJC Scopus subject areas

  • Bioengineering
  • Chemistry(all)
  • Materials Science(all)
  • Condensed Matter Physics
  • Mechanical Engineering

Cite this

Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival. / Lopez-Bertoni, Hernando; Kozielski, Kristen L.; Rui, Yuan; Lal, Bachchu; Vaughan, Hannah; Wilson, David R.; Mihelson, Nicole; Eberhart, Charles G; Laterra, John J; Green, Jordan.

In: Nano Letters, Vol. 18, No. 7, 11.07.2018, p. 4086-4094.

Research output: Contribution to journalArticle

@article{d27e79016c7c4fb6b089b7984a7cc32d,
title = "Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival",
abstract = "Despite our growing molecular-level understanding of glioblastoma (GBM), treatment modalities remain limited. Recent developments in the mechanisms of cell fate regulation and nanomedicine provide new avenues by which to treat and manage brain tumors via the delivery of molecular therapeutics. Here, we have developed bioreducible poly(β-amino ester) nanoparticles that demonstrate high intracellular delivery efficacy, low cytotoxicity, escape from endosomes, and promotion of cytosol-targeted environmentally triggered cargo release for miRNA delivery to tumor-propagating human cancer stem cells. In this report, we combined this nanobiotechnology with newly discovered cancer stem cell inhibiting miRNAs to develop self-assembled miRNA-containing polymeric nanoparticles (nano-miRs) to treat gliomas. We show that these nano-miRs effectively intracellularly deliver single and combination miRNA mimics that inhibit the stem cell phenotype of human GBM cells in vitro. Following direct intratumoral infusion, these nano-miRs were found to distribute through the tumors, inhibit the growth of established orthotopic human GBM xenografts, and cooperatively enhance the response to standard-of-care γ radiation. Co-delivery of two miRNAs, miR-148a and miR-296-5p, within the bioreducible nano-miR particles enabled long-term survival from GBM in mice.",
keywords = "bioreducible, brain cancer, cancer stem cell, miRNA, nanomedicine, polymer",
author = "Hernando Lopez-Bertoni and Kozielski, {Kristen L.} and Yuan Rui and Bachchu Lal and Hannah Vaughan and Wilson, {David R.} and Nicole Mihelson and Eberhart, {Charles G} and Laterra, {John J} and Jordan Green",
year = "2018",
month = "7",
day = "11",
doi = "10.1021/acs.nanolett.8b00390",
language = "English (US)",
volume = "18",
pages = "4086--4094",
journal = "Nano Letters",
issn = "1530-6984",
publisher = "American Chemical Society",
number = "7",

}

TY - JOUR

T1 - Bioreducible Polymeric Nanoparticles Containing Multiplexed Cancer Stem Cell Regulating miRNAs Inhibit Glioblastoma Growth and Prolong Survival

AU - Lopez-Bertoni, Hernando

AU - Kozielski, Kristen L.

AU - Rui, Yuan

AU - Lal, Bachchu

AU - Vaughan, Hannah

AU - Wilson, David R.

AU - Mihelson, Nicole

AU - Eberhart, Charles G

AU - Laterra, John J

AU - Green, Jordan

PY - 2018/7/11

Y1 - 2018/7/11

N2 - Despite our growing molecular-level understanding of glioblastoma (GBM), treatment modalities remain limited. Recent developments in the mechanisms of cell fate regulation and nanomedicine provide new avenues by which to treat and manage brain tumors via the delivery of molecular therapeutics. Here, we have developed bioreducible poly(β-amino ester) nanoparticles that demonstrate high intracellular delivery efficacy, low cytotoxicity, escape from endosomes, and promotion of cytosol-targeted environmentally triggered cargo release for miRNA delivery to tumor-propagating human cancer stem cells. In this report, we combined this nanobiotechnology with newly discovered cancer stem cell inhibiting miRNAs to develop self-assembled miRNA-containing polymeric nanoparticles (nano-miRs) to treat gliomas. We show that these nano-miRs effectively intracellularly deliver single and combination miRNA mimics that inhibit the stem cell phenotype of human GBM cells in vitro. Following direct intratumoral infusion, these nano-miRs were found to distribute through the tumors, inhibit the growth of established orthotopic human GBM xenografts, and cooperatively enhance the response to standard-of-care γ radiation. Co-delivery of two miRNAs, miR-148a and miR-296-5p, within the bioreducible nano-miR particles enabled long-term survival from GBM in mice.

AB - Despite our growing molecular-level understanding of glioblastoma (GBM), treatment modalities remain limited. Recent developments in the mechanisms of cell fate regulation and nanomedicine provide new avenues by which to treat and manage brain tumors via the delivery of molecular therapeutics. Here, we have developed bioreducible poly(β-amino ester) nanoparticles that demonstrate high intracellular delivery efficacy, low cytotoxicity, escape from endosomes, and promotion of cytosol-targeted environmentally triggered cargo release for miRNA delivery to tumor-propagating human cancer stem cells. In this report, we combined this nanobiotechnology with newly discovered cancer stem cell inhibiting miRNAs to develop self-assembled miRNA-containing polymeric nanoparticles (nano-miRs) to treat gliomas. We show that these nano-miRs effectively intracellularly deliver single and combination miRNA mimics that inhibit the stem cell phenotype of human GBM cells in vitro. Following direct intratumoral infusion, these nano-miRs were found to distribute through the tumors, inhibit the growth of established orthotopic human GBM xenografts, and cooperatively enhance the response to standard-of-care γ radiation. Co-delivery of two miRNAs, miR-148a and miR-296-5p, within the bioreducible nano-miR particles enabled long-term survival from GBM in mice.

KW - bioreducible

KW - brain cancer

KW - cancer stem cell

KW - miRNA

KW - nanomedicine

KW - polymer

UR - http://www.scopus.com/inward/record.url?scp=85049236956&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049236956&partnerID=8YFLogxK

U2 - 10.1021/acs.nanolett.8b00390

DO - 10.1021/acs.nanolett.8b00390

M3 - Article

C2 - 29927251

AN - SCOPUS:85049236956

VL - 18

SP - 4086

EP - 4094

JO - Nano Letters

JF - Nano Letters

SN - 1530-6984

IS - 7

ER -